About 200 reports

  • A) Global immunology market size
  • IMMUNOLOGY SPECIALIZATION, 2017

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth Summary Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5-7% of people in Western populations. Although they are often...

  • Immunology
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • IMMUNOLOGY MARKET IN APAC
  • Market size: Global immunology market

About Immunology The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the...

  • Immunology
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Chapter ## provides an introduction to the report.

  • Health Services
  • Immunology
  • World
  • Demand
  • IMMUNOLOGY THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR KEY IMMUNOLOGY
  • A) Revenues in immunology by product type

Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth Summary Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. Although they are often disparate in terms of their symptoms and key patient demographics,...

  • Immunology
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG

Business Overview Product Portfoilio Financials SWOT Analysis FUTURE OUTLOOK OF THE MARKET ABBREVIATIONS APPENDIX: PRESS RELEASES Chart List List of Charts: Europe Immunology Market Size, 2013 - 2023 (US$M) Europe Immunology Market Size, by Region, 2013 - 2023 (US$M) Europe

  • Health Services
  • Immunology
  • Therapy
  • Europe
  • Market Size

Business Overview Product Portfoilio Financials SWOT Analysis FUTURE OUTLOOK OF THE MARKET ABBREVIATIONS APPENDIX: PRESS RELEASES Chart List List of Charts: Brazil Immunology Market Size, 2013 - 2023 (US$M) Brazil Immunology Market Size, by Region, 2013 - 2023 (US$M) Brazil

  • Immunology
  • Brazil
  • BRIC
  • China
  • Market Size
  • Immunology
  • 8.3 IMMUNOLOGY AND INFECTIOUS DISEASES

The humanized mouse models market is projected to grow at a CAGR of 9.9% and humanized rat models market is projected to grow at a CAGR of 8.4%. The humanized mouse models market is projected to reach USD 128.9 million by 2022 from USD 80.3 million in 2017, at a CAGR of 9.9% during the forecast period. The humanized rat...

  • Immunology
  • North America
  • United States
  • World
  • Horizon Discovery
  • 3.4.4 Immunology
  • 4.2.4 Immunology

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth and...

  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • Market Size
  • IMMUNOLOGY DRUGS MARKET, 7MM, EPIDEMIOLOGY OF KEY IMMUNOLOGY INDICATIONS, 2018
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, PIPELINE FOR KEY IMMUNOLOGY INDICATIONS BY STAGE

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs Summary Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5-7% of people in Western populations. Although they are...

  • Healthcare
  • Immunology
  • World
  • Company Financials
  • Forecast
  • La Jolla Institute for Allergy & Immunology - Locations And Subsidiaries
  • La Jolla Institute for Allergy & Immunology, Key Competitors

Summary La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers.The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and asthma, cancer,...

  • Health Services
  • Immunology
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Institute for Research in Immunology and Cancer, Key Competitors
  • Institute for Research in Immunology and Cancer - Locations And Subsidiaries

Summary Institute for Research in Immunology and Cancer (IRICoR), a subsidiary of University of Montreal is a non-profit research institute that offers drug discovery and commercialization services.The institute offers discovery, development and commercialization of novel drugs in oncology. It has invested in innovative...

  • Health Services
  • Immunology
  • Pharmaceutical
  • Therapy
  • Canada
  • Immunology Market
  • Versatile Innovation in Immunology, Global,

Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential Summary Immunology is one of the largest therapy areas, with a total of 2,145 products in active development, trailing only oncology, infectious diseases and central nervous system disorders in...

  • Health Services
  • Healthcare
  • Immunology
  • World
  • Deals & Alliance
  • PROPORTION OF PEANUT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF PEANUT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS

Peanut Allergy Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Peanut Allergy Global Clinical Trials Review, H1, 2018" provides an overview of Peanut Allergy clinical trials scenario.This report provides top line data relating to the clinical trials on Peanut...

  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Aimmune Therapeutics, Inc.
  • SYNTHETIC PEPTIDES TO AGONIZE FPR1/2 FOR IMMUNOLOGY AND INFECTIOUS DISEASE - DRUG PROFILE
  • SYNTHETIC PEPTIDES TO ANTAGONIZE FPR1/2 FOR IMMUNOLOGY AND INFECTIOUS DISEASE - DRUG PROFILE

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2017 Summary N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - N-formyl peptide...

  • Immunology
  • Pathology
  • Therapy
  • World
  • Product Initiative
  • 4.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, 2017
  • 5.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, 2016

Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals Summary GlobalData’s "Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers...

  • Immunology
  • Neurology
  • World
  • Company
  • Deals & Alliance
  • PROPORTION OF PEMPHIGUS VULGARIS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2018*
  • PROPORTION OF PEMPHIGUS VULGARIS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus Vulgaris clinical trials scenario.This report provides top line data relating to the clinical trials...

  • Autoimmune Disease
  • Immunology
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF PEMPHIGUS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • PROPORTION OF PEMPHIGUS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2018*

Pemphigus Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Pemphigus Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus clinical trials scenario.This report provides top line data relating to the clinical trials on Pemphigus. Report...

  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MYASTHENIA GRAVIS TO IMMUNOLOGY CLINICAL TRIALS
  • Proportion of Myasthenia Gravis to Immunology Clinical Trials, G7 Countries (%), 2016*

Myasthenia Gravis Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2018" provides an overview of Myasthenia Gravis clinical trials scenario.This report provides top line data relating to the clinical trials on...

  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • Product Initiative
  • 7.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, Q4 2016
  • Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 Summary GlobalData’s “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016”, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As)...

  • Endocrine Disease
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • PROPORTION OF LUNG TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF LUNG TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS

Lung Transplant Rejection Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Lung Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Lung Transplant Rejection clinical trials scenario. This report provides top line data relating...

  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • Novartis AG
  • PROPORTION OF HEREDITARY ANGIOEDEMA (HAE) (C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY) TO IMMUNOLOGY CLINICAL TRIALS, E7
  • PROPORTION OF HEREDITARY ANGIOEDEMA (HAE) (C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY) TO IMMUNOLOGY CLINICAL TRIALS, E7

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Hereditary Angioedema (HAE)...

  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • Product Initiative
  • PROPORTION OF MILK ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MILK ALLERGY TO IMMUNOLOGY CLINICAL TRIALS

Milk Allergy Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Milk Allergy Global Clinical Trials Review, H2, 2017" provides an overview of Milk Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Milk Allergy....

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF MUCOCUTANEOUS LYMPH NODE SYNDROME (KAWASAKI DISEASE) TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%),
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MUCOCUTANEOUS LYMPH NODE SYNDROME (KAWASAKI DISEASE) TO IMMUNOLOGY CLINICAL TRIALS

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2017" provides an overview of Mucocutaneous Lymph Node Syndrome (Kawasaki...

  • Immunology
  • Pharmaceutical
  • World
  • Product Initiative
  • Mitsubishi Corporation
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*

Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2017" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating to...

  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF CUTANEOUS LUPUS ERYTHEMATOSUS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF CUTANEOUS LUPUS ERYTHEMATOSUS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the...

  • Clinical Trial
  • Hospital
  • Immunology
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF JUVENILE RHEUMATOID ARTHRITIS TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF JUVENILE RHEUMATOID ARTHRITIS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*

Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017" provides an overview of Juvenile Rheumatoid Arthritis clinical trials scenario. This report provides top line data...

  • Immunology
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Pfizer Inc.
  • PROPORTION OF KIDNEY TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF KIDNEY TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating...

  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • Novartis AG
  • PROPORTION OF POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS

Pollen Allergy Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Pollen Allergy Global Clinical Trials Review, H1, 2018" provides an overview of Pollen Allergy clinical trials scenario.This report provides top line data relating to the clinical trials on Pollen...

  • Clinical Trial
  • Immunology
  • Therapy
  • World
  • Allergy Therapeutics plc
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF LUPUS NEPHRITIS TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF LUPUS NEPHRITIS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*

Lupus Nephritis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H2, 2017" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus...

  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • World
  • Product Initiative
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

Chronic Inflammation Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Inflammation Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...

  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • Product Initiative